FIGURE

Fig. 6

ID

ZDB-FIG-250506-82

Publication

Dharshan et al., 2024 - Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non-alcoholic fatty liver disease in vivo zebrafish model

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

Locomotion activity of NAFLD-induced adult zebrafish. The graph represents (A) Bodyweight. (B) The movement of NAFLD and treatment fish. (C) The distance traveled. (D) Velocity. NAFLD-HCD induced larvae, Vit D3 at the concentration of 0.1 µM, DOPA-33 compound at 10 µM, Vit D3 (0.1 µM) + DOPA-33 (10 µM). All the assays were conducted in triplicates as three independent experiments. The results are presented as mean ± standard deviation (SD). The symbol * indicates a significant difference between the tested samples and the NAFLD group (**p < 0.0021, ***p < 0.0002, ****p < 0.0001, and ns = not significant). NAFLD—non-alcoholic fatty liver disease; Vit D3—vitamin D3; DOPA-33—dioxopiperidinamide-33; Vit D3 + DOPA-33—vitamin D3 + dioxopiperidinamide-33.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biotechnol Appl Biochem